Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (5)

1

Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity : Evaluation of 5676 Phase 1 Passed Structures

enthalten in: Journal of medical virology | 2022

von Chiu, W. | Verschueren, L. | Van den Eynde, C. | +11

2

In vitro activity of itraconazole against SARS-CoV-2

enthalten in: Journal of medical virology | 2021

von Van Damme, E. | De Meyer, S. | Bojkova, D. | +8

3

Week 96 resistance analyses of the once-daily, single-tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials

enthalten in: Journal of medical virology | 2021

von Lathouwers, E. | Weinsteiger, S. | Baugh, B. | +5

4

Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE

enthalten in: Journal of medical virology | 2016

von Van Eygen, V. | Thys, K. | Van Hove, C. | +5

5

Deep sequencing analysis of HIV‐1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE

enthalten in: Journal of medical virology | 2016

von Van Eygen, V. | Thys, K. | Van Hove, C. | +5

1
[1]